Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Aug 25, 2021

Sanjay Shukla is the President and CEO of aTyr Pharma, focusing on the extracellular functionality and signaling pathways of tRNA synthetases. The lead clinical product candidate ATYR1923 is a potential disease-modifying therapy for patients with severe inflammatory lung diseases, including interstitial lung disease...


Aug 25, 2021

Sanjay Shukla is the President and CEO of aTyr Pharma, focusing on the extracellular functionality and signaling pathways of tRNA synthetases. The lead clinical product candidate ATYR1923 is a potential disease-modifying therapy for patients with severe inflammatory lung diseases, including interstitial lung disease...


May 25, 2021

Dr. Ian Walters is CEO of Portage Biotech is building a pipeline of novel immunotherapies for the treatment of cancer particularly for patients who do not respond to current therapies.  The key is stimulating a type of immune cell called invariant natural killer T-cell which works with the adaptive immune system to...


May 25, 2021

Dr. Ian Walters is CEO of Portage Biotech is building a pipeline of novel immunotherapies for the treatment of cancer particularly for patients who do not respond to current therapies.  The key is stimulating a type of immune cell called invariant natural killer T-cell which works with the adaptive immune system to...


Apr 6, 2021

Jonathan Rigby, CEO, Revolo Biotherapeutics discusses the company's revolutionary therapies powered to reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases, with less frequent chronic dosing and without suppression of the immune system. A goal that others...